Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance ...

Noroviruses are increasingly recognized as an important cause of chronic gastroenteritis in immunocompromised patients, as reflected by the growing number of clinical case reports. This review ...

This update is particularly critical for those most vulnerable to severe illness.Dr. James McDonald, New York State Health ...

It was no surprise to many in healthcare that it advised a second dose for those 65 and older or for those younger who are moderately or severely immunocompromised. What was somewhat unexpected ...

ExeVir's XVR013m, COVID-19 program focuses on addressing the high unmet medical need to protect and treat immunocompromised and elderly individuals that account for respectively 4% and 10% of the ...

The CDC now recommends that people 65 and older or those who are moderately to severely immunocompromised consult a health care provider about a second COVID-19 vaccine dose.

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

Now is the time for older adults to start thinking about how they will protect their health this winter, especially those ...

But immunocompromised patients are usually left out of large clinical trials that assess new treatments and vaccines, leaving a data gap that hampers clinical care. On September 10, experts across ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...